OR WAIT null SECS
March 28, 2022
US commercialization of EVO will begin immediately in select cities across the country.
Case report: Combination treatment proves effective for choroidal metastasis from breast cancer patient
Alcon completes acquisition of Aerie Pharmaceuticals
Words matter: Update how you talk to your patients
FDA approves intravenous injection for delayed onset of stage 3 type 1 diabetes
